Stock Selection: DeepSeek's picks for 2026-10-14
DeepSeek picked LQDA, ENVX, VIR, BABA, ASML for a 1-day horizon. Portfolio return vs SPY: -0.57%. Picks that beat SPY: 40%.
| Experiment | Stock Selection |
|---|---|
| Model | DeepSeek |
| Prompt version | stock-selection-v8 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-14 |
| Measured to | 2026-10-15 |
| Benchmark | SPY |
| Status | Settled |
| Portfolio return vs SPY | -0.57% |
| Picks that beat SPY | 40% |
| Benchmark return | -0.16% |
The picks
| Rank | Symbol | Return | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|
| 1 | LQDA | +1.63% | 80% | +1.79% | Yes |
| 2 | ENVX | -1.19% | 65% | -1.03% | No |
| 3 | VIR | -0.38% | 60% | -0.22% | No |
| 4 | BABA | +0.32% | 60% | +0.48% | Yes |
| 5 | ASML | -4.04% | 55% | -3.88% | No |
The model's market view
US equities are navigating a volatile session on October 14, 2026. September CPI came in hotter than expected at 3.7% year-over-year, fueling rate-hike concerns and pressuring broad indices. However, idiosyncratic catalysts are driving sharp moves in specific names, creating opportunities for outsized single-session gains relative to SPY. The market is rewarding clear, company-specific positive news, particularly in biotech and small-cap industrials, while semiconductor and large-cap tech names face mixed reactions to earnings. SPY is likely to remain range-bound or slightly negative as macro headwinds offset sector strength.
Why each pick
LQDA
Liquidia surged over 40% in premarket trading after announcing a $380.7 million global settlement with United Therapeutics that resolves all pending litigation and removes a major overhang on its inhaled drug Yutrepia. The stock was trading around $34.91 at 10:00 AM ET, and momentum from such a transformative legal resolution often persists through the session. Risks include profit-taking after the sharp spike and potential dilution from the settlement payments, but the removal of uncertainty is a powerful catalyst for a one-day horizon. Reference price is an intraday quote from Kabutan.
ENVX
Enovix jumped 10.4% in premarket trading after securing a 100,000-unit battery order from a multinational drone systems provider. The order converts a pipeline opportunity into backlog and highlights Enovix's strategic value as a non-Chinese, TAA-compliant battery supplier for defense applications. The stock was trading around $2.80 after hours, reflecting strong buying interest. Risks include the low absolute share price, recent analyst price target cuts, and the speculative nature of small-cap defense plays. Reference price is the after-hours quote from StockAnalysis.com.
VIR
Vir Biotechnology shares climbed 8.2% in premarket trading after signing a collaboration and license agreement with Gilead Sciences to develop next-generation T-cell engagers for solid tumors. The deal includes $135 million in near-term payments and up to $1.74 billion in milestones, validating Vir's platform. The stock was trading around $11.00 intraday. Risks include the clinical-stage nature of the pipeline and potential reversal if the broader biotech sector sells off on rate concerns. Reference price is the intraday quote from Robinhood.
BABA
Alibaba's US-listed shares rose nearly 2% in premarket trading after unveiling its new Qwen AI smart glasses, priced from $450, positioning the company to compete with Meta in the AI wearables space. The stock was trading around $111.36 at 11:22 AM ET, showing resilience despite a hot CPI print. The launch signals Alibaba's commitment to monetizing AI through consumer hardware, a potential new growth vector. Risks include China macro headwinds, competitive pressures from Meta, and the modest immediate revenue impact of the glasses. Reference price is the live intraday quote from Yahoo Finance.
ASML
ASML reported third-quarter earnings that beat expectations, with EPS of $14.88 on revenue of $13.42 billion versus estimates of $12.47 and $13.18 billion. The stock initially surged in premarket but pulled back, trading around $1,720.72 intraday. The strong results and raised guidance for Q4 reinforce the AI-driven demand narrative for semiconductor equipment. Risks include profit-taking after the initial pop, broader tech weakness from rate-hike fears, and the stock's high valuation. Reference price is the intraday quote from Sina Finance.
Other models on the same run
| Model | Picks | Portfolio return vs SPY | Picks that beat SPY |
|---|---|---|---|
| GPT-6 | XLE, XOM, TSM, BLK, XLP | +0.15% | 40% |
| Muse Spark 1.1 | AAPL, XLV, GOOGL, MSFT, NVDA | -0.11% | 40% |
| Gemini 3 Pro | NVDA, TSLA, AAPL, AMZN, MSFT | -0.94% | 20% |
| Perplexity | VLO, DINO, XLE, LQDA, JPM | -0.34% | 40% |
| Grok 4 | LQDA, BSP, XLE, HALO, VLO | +2.35% | 60% |
Written up on ForecastNest Insights: Stock Selection: DeepSeek's picks for 2026-10-14.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.